Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Sandmaier

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Leukemia|February 1, 1991
Biochemical characterization of a unique canine myeloid antigenB M Sandmaier, F G Schuening, J A Bianco, et al.
Transplant Immunology|December 1, 1996
An anti-CD44 antibody does not enhance engraftment of DLA-identical marrow after low-dose total body irradiationB M Sandmaier, R Storb, Y Liu, et al.
Bone Marrow Transplantation|January 10, 2017
Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemiaM S Thakar, C Bonfim, M C Walters, et al.
Bone Marrow Transplantation|January 23, 2008
Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimensO Sala-Torra, P J Martin, B Storer, et al.
Experimental Hematology|September 1, 1989
Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factorF G Schuening, R Storb, S Goehle, et al.
Bone Marrow Transplantation|June 29, 2000
Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccineL A Holmberg, D V Oparin, T Gooley, et al.
Bone Marrow Transplantation|May 24, 2016
Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severityS Z Aki, Y Inamoto, P A Carpenter, et al.
Bone Marrow Transplantation|November 24, 2004
Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioningM E D Flowers, F Traina, B Storer, et al.
Leukemia|November 5, 2005
Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysisB L Scott, B M Sandmaier, B Storer, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|August 14, 2001
Non-myeloablative hematopoietic stem cell transplantationM Maris, B M Sandmaier, D G Maloney, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Leukemia|February 1, 1991
Biochemical characterization of a unique canine myeloid antigenB M Sandmaier, F G Schuening, J A Bianco, et al.
Transplant Immunology|December 1, 1996
An anti-CD44 antibody does not enhance engraftment of DLA-identical marrow after low-dose total body irradiationB M Sandmaier, R Storb, Y Liu, et al.
Bone Marrow Transplantation|January 10, 2017
Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemiaM S Thakar, C Bonfim, M C Walters, et al.
Bone Marrow Transplantation|January 23, 2008
Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimensO Sala-Torra, P J Martin, B Storer, et al.
Experimental Hematology|September 1, 1989
Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factorF G Schuening, R Storb, S Goehle, et al.
Bone Marrow Transplantation|June 29, 2000
Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccineL A Holmberg, D V Oparin, T Gooley, et al.
Bone Marrow Transplantation|May 24, 2016
Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severityS Z Aki, Y Inamoto, P A Carpenter, et al.
Bone Marrow Transplantation|November 24, 2004
Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioningM E D Flowers, F Traina, B Storer, et al.
Leukemia|November 5, 2005
Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysisB L Scott, B M Sandmaier, B Storer, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|August 14, 2001
Non-myeloablative hematopoietic stem cell transplantationM Maris, B M Sandmaier, D G Maloney, et al.
Pageof 6